A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization-Reference-Cited by-同舟云学术

A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization

Published:2020-09-15 Issue:1 Volume:24 Page:97-110
ISSN:0969-6970
Container-title:Angiogenesis
language:en
Short-container-title:Angiogenesis

Author:

Chen Jinying,Lin Fan-Li,Leung Jacqueline Y. K.,Tu Leilei,Wang Jiang-Hui,Chuang Yu-Fan,Li Fan,Shen Hsin-Hui,Dusting Gregory J.,Wong Vickie H. Y.,Lisowski Leszek,Hewitt Alex W.,Bui Bang V.,Zhong Jingxiang,Liu Guei-Sheung^ORCID

Funder

National Health and Medical Research Council

The Ophthalmic Research Institute of Australia

National Natural Science Foundation of China

Rebecca L. Cooper Medical Research Foundation

National Science Centre, Republic of Poland

Department of Science and Higher Education of Ministry of National Defense, Republic of Poland

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Biochemistry,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10456-020-09745-7.pdf

Reference26 articles.

1. Sun Y, Smith LEH (2018) Retinal vasculature in development and diseases. Annu Rev Vis Sci 4:101–122

2. Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193–1203

3. Mehta H, Tufail A, Daien V, Lee AY, Nguyen V, Ozturk M, Barthelmes D, Gillies MC (2018) Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Prog Retin Eye Res 65:127–146. https://doi.org/10.1016/j.preteyeres.2017.12.002

4. Avery RL, Gordon GM (2016) Systemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis. JAMA Ophthalmol 134(1):21–29. https://doi.org/10.1001/jamaophthalmol.2015.4070

5. Rakoczy EP, Lai CM, Magno AL, Wikstrom ME, French MA, Pierce CM, Schwartz SD, Blumenkranz MS, Chalberg TW, Degli-Esposti MA, Constable IJ (2015) Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial. Lancet 386(10011):2395–2403. https://doi.org/10.1016/s0140-6736(15)00345-1

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice;Biomedicines;2023-07-06

2. Diabetic retinopathy: emerging concepts of current and potential therapy;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-07-04

3. Pathological angiogenesis: mechanisms and therapeutic strategies;Angiogenesis;2023-04-15

4. A tunable genome editing system of the prime editor mediated by dihydrofolate reductase;Journal of Genetics and Genomics;2023-03

5. Nanoparticle-mediated corneal neovascularization treatments: Toward new generation of drug delivery systems;Chinese Chemical Letters;2023-03